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Abstract
Echocardiography has the ability to noninvasively explore hemodynamic variables during
pharmacologic or exercise stress test in patients with heart failure. In this review, we detail some
important potential applications of stress echocardiography in patients with heart failure. In
patients with coronary artery disease and chronic LV dysfunction, dobutamine stress
echocardiography is able to distinguish between viable and fibrotic tissue to make adequate clinical
decisions. Exercise testing, in combination with echocardiographic monitoring, is a method of
obtaining accurate information in the assessment of functional capacity and prognosis. Functional
mitral regurgitation is a common finding in patients with dilated and ischaemic cardiomyopathy and
stress echocardiography in the form of exercise or pharmacologic protocols can be useful to
evaluate the behaviour of mitral regurgitation. It is clinical useful to search the presence of
contractile reserve in non ischemic dilated cardiomyopathy such as to screen or monitor the
presence of latent myocardial dysfunction in patients who had exposure to cardiotoxic agents.
Moreover, in patients with suspected diastolic heart failure and normal systolic function, exercise
echocardiography could be able to demonstrate the existence of such dysfunction and determine
that it is sufficient to limit exercise tolerance. Finally, in the aortic stenosis dobutamine
echocardiography can distinguish severe from non-severe stenosis in patients with low
transvalvular gradients and depressed left ventricular function.
Background
The identification of viable hibernating myocardium in
patients with coronary artery disease and chronic left ven-
tricular (LV) dysfunction is, up to today, the most com-
mon use of stress echocardiography in patients with heart
failure. However, to search viable myocardium or the
presence of contractile reserve is only one of plugs of the
physiopathologic puzzle in a failing heart (Figure 1 and
2). If we consider the ability of echocardiography to pro-
vide valuable haemodynamic information accurately and
non-invasively, it is ideally suited for application during
stress testing to objectively assess other physiopathologic
components of heart failure. These include the study of
exercise physiology, the presence and the behaviour of
concomitant mitral regurgitation (MR), the prediction of
response to resynchronization therapy etc.
Therefore, the present review will detail some important
potential applications of stress echocardiography in
patients with heart failure in the evaluation of the
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Physiopathologic components of systolic heart failure that can be potentially explored with stress echocardiography. Figure 1
Physiopathologic components of systolic heart failure that can be potentially explored with stress echocardiography.
Physiopathologic components of diastolic heart failure assessable with stress echo Figure 2
Physiopathologic components of diastolic heart failure assessable with stress echo.Cardiovascular Ultrasound 2004, 2:11 http://www.cardiovascularultrasound.com/content/2/1/11
Page 3 of 14
(page number not for citation purposes)
different clinical and physiopathologic aspects of heart
failure syndrome.
Systolic heart failure
Searching the myocardial viability
The most common cause of heart failure in the Western
world is coronary artery disease, accounting for up to 60%
of cases [1]. In patients with coronary artery disease and
chronic LV dysfunction, it is crucial to distinguish
between viable and fibrotic tissue to make adequate clini-
cal decisions. Noncontractile but viable myocardium may
correspond to different states that are important but diffi-
cult to distinguish, i.e., ischemia, stunning, nontransmu-
ral infarction, or hibernation and in individual patients
these pictures may coexist [2].
After brief episodes of coronary occlusion and reflow a
reversible global LV dysfunction can occur. This phenom-
enon was called myocardial stunning [3]. It is character-
ized as prolonged mechanical dysfunction after coronary
reflow despite resumption of normal perfusion and lack
of permanent tissue damage. Stunning seems to result
from alterations in contractile proteins in response to sub-
lethal ischemic insults. This phenomenon can occur in
several settings, including after acute reperfused myocar-
dial infarction and after CABG. In humans, the return of
functional recovery may require days to weeks [4]. Hence,
diagnostic methods to distinguish stunning from necrosis
are particularly relevant for clinical investigation and
management in patients with acute, severe LV dysfunction
or cardiogenic shock after revascularization. Persistent
wall motion abnormalities can be observed by echocardi-
ography at a time when chest pain, ST segment deviation,
and regional perfusion had recovered. The presence of
contractile reserve during dobutamine infusion identifies
the stunning but viable myocardium from myocardial
necrosis.
The term "Hibernating myocardium" was first termed by
Rahimtoola to indicate the state of reversible dysfunc-
tional myocardium, which was considered to be the result
of a state of persistently impaired myocardial function at
rest, caused by reduced coronary blood flow, and which
could be partially or completely restored to normal either
by improving blood flow or reducing oxygen demand [5].
Echocardiography can detect viable myocardium during
infusion of drugs which have ability to elicit an enhanced
contractile response by recruiting contractile proteins. At
least two drugs have these proprieties: the dobutamine, a
synthetic β1 agonist with additional α1- and β2-stimulat-
ing properties and the enoximone that inhibits cyclic ade-
nosine monophosphate-specific phosphosdiesterase
[6,7]. Routinely, the dobutamine is the most common
stressor used, whereas the enoximone is particularly use-
ful in patients on beta-blocker therapy [7,8]. The mecha-
nism by which dobutamine stimulation elicits a
contractile response in hypoperfused dysfunctional seg-
ments without precipitating ischemia has been demon-
strated by Sun et al. [6]. By using positron emission
tomography and echocardiography, they demonstrated
that the improvement in contractile function during dob-
utamine infusion was associated with a concomitant
increase in myocardial blood flow. The increase in myo-
cardial blood flow occurs because there is persistent,
albeit reduced, coronary flow reserve distal to a stenosis
which dobutamine may exploit. Another mechanism
whereby contractile response may be elicited during dob-
utamine infusion is through its peripheral vasodilator
effect, which causes reduction in LV end-systolic wall
stress by reducing afterload [6]. Moreover, dipyridamole
echocardiography (up to 0.84 mg/kg over 10 minutes)
can identify regions with myocardial viability [9]. Dipyri-
damole leads to transiently increased coronary flow,
which leads to improved contractility in viable myocar-
dium [9]. A small study comparing dipyridamole with
dobutamine revealed 93% concordance [10]. Combined
dipyridamole-dobutamine (low-dose dipyridamole fol-
lowed by low-dose dobutamine) has also been proposed
and found to recruit a contractile reserve in some asyner-
gic segments that were nonresponders after dobutamine
or dipyridamole alone [11].
An initial evaluation of end diastolic wall thickness of aki-
netic segments with resting echocardiography can be used
as an initial screening technique for assessment of viabil-
ity. Indeed, akinetic regions with an end diastolic wall
thickness <6 mm do not contain viable myocardium and
do not improve in function after revascularization [12].
However, in segments with a thickness ≥ 6 mm, addi-
tional testing is needed because approximately 40% of
these regions do not contain viable myocardium and will
not improve after revascularization [12]. Therefore, myo-
cardial thinning should not be equated with the lack of
myocardial viability, and in some patients, these regions
can improve in contractile function after revascularization
[13]. The detection of subendocardial infarcts became
clinically relevant because the quantification of non-via-
ble myocardium in addition to viable myocardium in that
region of LV is important in predicting contractile
improvement following revascularization. Thus, the ratio
of viable to total myocardium (viable plus non-viable) in
the dysfunctional region was more accurate that absolute
amount of viable myocardium alone in predicting func-
tional improvement [13]. Unfortunately, currently availa-
ble techniques, such as single photon emission computed
tomography, dobutamine stress echocardiography and
positron emission tomography are still insufficient to pro-
vide a comprehensive assessment including the evalua-Cardiovascular Ultrasound 2004, 2:11 http://www.cardiovascularultrasound.com/content/2/1/11
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tion of subendocardial infraction with respect to magnetic
resonance imaging [14].
During stress echocardiography is possible to observe four
response patterns based on regional wall function: nor-
mal, ischemic, viable and necrotic. In the normal
response, a segment is normokinetic at rest and normal or
hyperkinetic during stress. In the ischemic response, a seg-
ment worsens its function during stress from normokine-
sis to dyssynergy. In the necrotic response, a segment
akinesia remains akinetic during stress. In the viability
response, a segment with resting dysfunction improves
during stress. During pharmacologic stress, a viable
response at low dose can be followed by ischemic
response at high dose (biphasic response). This biphasic
response is suggestive of viability and ischemia, with jeop-
ardized myocardium fed by a critically stenosed coronary
artery [15]. A resting akinesia which becomes dyskinesia
during stress reflects a purely passive mechanical phe-
nomenon and should not be considered a true active
ischemia.
The overall sensitivity and specificity of dobutamine
echocardiography for predicting recovery of regional func-
tion after revascularization was 84% and 81% respectively
[16]. In a study by Afridi et al., the best predictive value for
recovery of function after revascularization was most
often noted in patients demonstrating an ischemic
response during low and high doses of dobutamine infu-
sion [17]. On the other hand, sustained improvement of
regional function during dobutamine infusion was a poor
marker of recovery function.
Sensitivity of dobutamine echocardiography may be
affected by several factors such as the severe reduction of
myocardial blood flow that can preclude the contractile
response, the premature interruption of dobutamine infu-
sion, resting tachycardia that may renders the myocar-
dium ischemic and dobutamine can only augment
ischemia [16]. On the contrary, the specificity may be
affected by the tethering effect, the injured subendocardial
portion of myocardium that does not respond to dob-
utamine when the infarction is confined to subendocar-
dium, and also specificity may be reduced in myocardial
regions that do not develop an ischemic response [16].
The main clinical issue to search the myocardial viability
is that patients with evidence of hibernating myocardium
who do not undergo revascularization have poor progno-
sis with high incidence of cardiac events [18]. In contrast,
evidence of viable myocardium in patients undergoing
successful revascularization is associated with longer sur-
vival and improvement of both symptoms and LV func-
tion [19]. However, the presence of myocardial viability is
only relevant in patients with severely depressed LV func-
tion and has a prognostic impact only when a significant
amount of viable myocardium is present. Therefore, the
final end point of searching the myocardial viability is to
predict the recovery of global myocardial function after
revascularization. At this purpose there is a relation
between improvement in left ventricular ejection fraction
(LVEF) and the number of segments with contractile
reserve, indicating that extent of jeopardized but viable
myocardium determine the magnitude of improvement
of LV function after revascularization. Usually a level of ≥
4 viable segments, which corresponds an improvement in
wall motion score index >0.25 (about 20% of left ventri-
cle), is advised as a cutoff value to predict improvement of
LVEF [20]. However, despite the presence of substantial
viability, in some patients LVEF does not improve after
revascularization because not only the amount of dys-
functional but viable tissue but also LV remodelling and
enlargement determines the improvement in function fol-
lowing revascularization [21]. Thus, patients with a high
end systolic volume (≥ 140 ml) due to LV remodelling
have a low likelihood of improvement of global function
[21] (Figure 3).
Assessing the functional capacity
In most patients with chronic heart failure, symptoms are
not present at rest but become limiting with exercise.
Despite this, the major measures used to characterise the
symptoms, the severity, the mechanisms and the progno-
sis of heart failure are obtained at rest. Exercise testing, in
combination with echocardiographic monitoring, may be
an attractive and practical method of obtaining accurate
information which can aid in the diagnosis of heart failure
as well as the assessment of functional limitation and
prognosis. Exercise rather than dobutamine is the stressor
of choice to evaluate functional capacity due to the possi-
bility to combine echocardiographic variables with com-
mon parameters available during physiologic exercise.
Symptom limited exercise testing can be undertaken using
either treadmill or bicycle exercise protocols. Available
data about the safety of exercise testing in patients with
significant heart failure suggest a very low incidence of
serious adverse events such as arrythmias or
hypothension.
The echocardiographic monitoring during exercise testing
may have an additional value overt the conventional
parameters assessed during exercise testing such as func-
tional capacity, symptoms and peak oxygen uptake that
become part of the final interpretation. Indeed, several
haemodynamic parameters can be noninvasively
obtained with echocardiography such as LVEF at rest and
during stress deriving the contractile reserve, the behav-
iour of mitral valve function, the pulmonary artery pres-
sure, the right ventricular function, the diastolic functionCardiovascular Ultrasound 2004, 2:11 http://www.cardiovascularultrasound.com/content/2/1/11
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A schematic flow chart for searching segmental and global systolic function in chronic ischemic LV dysfunction Figure 3
A schematic flow chart for searching segmental and global systolic function in chronic ischemic LV dysfunction.
Table 1: Potential parameters obtainable during exercise echocardiography.
Common variables during exercise test Additional echocardiographic variables during exercise test
Duration of exercise Contractile reserve
Peak VO2 Mitral valve function
Anaerobic threshold Pulmonary systolic pressure
Oxygen pulse Right ventricular function
VO2 workload ratio Diastolic function
O2 saturation
LV Wall Motion Abnormalities 
Hypokinesia 
Viable 
Akinesia
Wall thickness  
> > 6 mm  < 6 mm 
Not Viable  Dobutamine ECHO 
- Sustained Improvement
- Biphasic Response
Not Improvement
->4 Viable Segments
- End Systolic Volume <140 ml
Revascularization 
with Improvement
of Global Function
Alternative therapy:
- Volumetric reduction;
- Transplantation;
-M y o b l a s t sCardiovascular Ultrasound 2004, 2:11 http://www.cardiovascularultrasound.com/content/2/1/11
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(Table 1). In this way, it is possible to observe the varia-
tion of the monitored variables and to correlate these with
the appearance of symptoms, i.e. impairment of global
contractile function followed by increase in pulmonary
pressure with dyspnoea. The critical level to define the
presence of contractile reserve is generally defined as an
increase of at least 5% (in absolute terms) in the global
LVEF [22] (Figure 4). The change in the systolic pulmo-
nary artery pressure (sPAP) at rest and during exercise is
among others, the most frequently utilized echocardio-
graphic variable. It can reliably be estimated by adding the
right atrial pressure derived from the tricuspid regurita-
tion jet velocity [23]. The right atrial pressure can be esti-
mated at rest by the response of inferior vena cava to deep
inspiration and assumed to be constant throughout exer-
cise. Sometimes the use of echocardiographic contrast
agents such as agitated saline solution may help to
enhance Doppler signals. Pulmonary hypertension deter-
mined by echocardiography has been defined as a peak of
sPAP >30 mmHg at rest and >45 mmHg during exercise
[24]. Right ventricular dysfunction predicts impaired exer-
cise capacity and decreased survival in patients with both
moderate and advanced heart failure [25]. There are
several clinically validated methods to detect right ven-
tricular dysfunction. Tricuspid annular plane systolic
excursion (TAPSE) visualized from the apical four-cham-
ber view is an easy measure and can be used a surrogate of
right ventricular function. A TAPSE value of 14 mm or less
means the presence of right ventricular dysfunction and is
a significant adverse prognostic indicator [26]. More
recently, the evalution of tricuspid systolic annular tissue
Doppler velocity has been introduced as index of right
ventricular function and a value less than 10.8 cm/s indi-
cates patients with abnormal right ventricular function
[27].
Echocardiographic apical four-chamber images (end-systolic frames) from two patients with and without contractile reserve Figure 4
Echocardiographic apical four-chamber images (end-systolic frames) from two patients with and without contractile reserve.Cardiovascular Ultrasound 2004, 2:11 http://www.cardiovascularultrasound.com/content/2/1/11
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Moreover, these evaluations are useful not only for the
diagnosis but also for predicting the outcome of patients
overt the symptoms of heart failure. Indeed, some patients
with marked reduction in myocardial contractility at rest,
but with good residual contractile reserve, have a favoura-
ble exercise capacity and prognosis, whereas patients with
mild symptoms and similar degree of abnormal myocar-
dial contractility at rest, but without contractile reserve,
have poor outcome [28]. Although a VO2max <14 ml/kg/
min is well known as a measure for deciding on eligibility
for cardiac transplantation, it has been clearly shown that
there is no absolute threshold for adverse prognosis and
that VO2max uptake should be considered as a continu-
ous variable. In term of discriminating survivors from non
survivors, it appears that VO2max <10 ml/kg/min defini-
tively defines high risk, while a value >18 ml/kg/min
defines low risk; those values in between may represent a
grey zone. Thus stress echocardiography yields the greatest
incremental prognostic value in patients with intermedi-
ate values of VO2max (10–14 ml/Kg/min) and helps to
further stratify the risk of patients with intermediate
(Table 2) [29].
Looking at the behaviour of mitral valve
MR is a common finding in heart failure patients. In
patients with dilated and ischaemic cardiomyopathy, the
MR is typically functional and reflects geometric
distortions of LV chamber, which displaces the normal
valve and subvalvar closing mechanisms. This functional
MR is a consequence of adverse LV remodelling and
increased sphericity of the chamber. It is typically
dynamic and a marker of adverse prognosis. The 5-year
survival of heart failure patients with functional MR
ranges from 39.9% to 48.7% depending on the degree of
MR [30].
Stress echocardiography in the form of exercise or phar-
macologic protocols can be useful in the assessment of
MR. Exercise echocardiography is usually preferred due to
the possibility to reproduce physiological setting. Even
though supine bike protocol allows to obtain good image
acquisition, upright bicycle or treadmill protocols are
more frequently utilized in the practical setting. Treadmill
exercises can be performed using the standard protocols
such as Bruce or modified Bruce, while gradual increase in
the bike workload of 20–25 W every 2–3 minutes is often
applied until the patients achieves either the target heart
rate or develops symptoms of fatigue or shortness of
breath. Sometimes, pharmacologic stress is used with
dobutamine protocol at low or intermediate doses infu-
sion. In the collection of echocardiographic data should
be included: the MR jet to evaluate the MR jet area and the
vena contracta width, the velocity time integrals (mitral
and aortic) to calculate the regugitant volume and the
effective regurgitant orifice area (EROA), the LV volumes
to assess the myocardial contractility and the tricuspid
regurgitant jet velocity to measure the sPAP that is an use-
ful index of the haemodynamic burden of MR.
Exercise echocardiography can play several roles in the
assessment of the behaviour of mitral valve in heart failure
patients. First, in symptomatic patients with LV dysfunc-
tion and a clinical picture suspicious for new or worsening
MR, but not evident at resting echo examination, exercise
echocardiography can demonstrate a worsening of MR
which helps to correlate this scenario with the patient's
symptoms (Figure 5) [31]. Second, LV contractility, in
presence of MR, can impair or improve during exercise
with consequent modification of MR. Patients with pres-
ence of contractile reserve show a decrease in MR [32],
whereas generally a fall in stroke volume is associated
with an increase in mitral regurgitant volume during iso-
metric exercise, which increases systemic resistances and
thereby afterload [33]. These observations support the
concept of presence of a vicious circle between LV func-
tion and behaviour of MR. Therefore, to study these
patients with exercise echocardiography may be impor-
tant for assessing the response of MR to medical therapy
and for the following prognostic implications. Indeed,
third, in patients with ischemic MR and LV dysfunction,
quantitative assessment of exercise-induced changes in
the degree of MR provides independent prognostic infor-
mation. Significant exercise-induced increases in MR
(increase in ERO ≥ 13 mm2 ) unmask patients at high risk
of poor outcome. The cardiac mortality rate of medically
treated patients with dynamic MR during exercise is 39%
at 20 months which represents excess mortality in patients
in functional class II or III (Figure 6) [34].
Finally, dobutamine protocol has a different role in the
contest of ischemic MR. Generally, in this setting it is used
to evaluate the behaviour of MR in relation with the pres-
ence or absence of myocardial viability (Figure 7). Dob-
utamine infusion has the ability to decrease MR volume
due to a reduction of afterload and mitral orifice size that
may occur as a result of the vasodilatory and inotropic
effects of dobutamine [35,36]. Therefore, if during
Table 2: Additive prognostic value of stress echo in patients with 
intermediate values of VO2max (10–14 ml/Kg/min).
Risk Low 
(5–10% year)
High 
(≥ 25–30% year)
Exercise capacity ≥ 8–10 min <8 min
Contractile reserve yes no
Pulmonary hypertension <45 mmHg >45 mmHg
Right ventricular dysfunction no yes
Mitral regurgitation ↓ or = ↑↑Cardiovascular Ultrasound 2004, 2:11 http://www.cardiovascularultrasound.com/content/2/1/11
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dobutamine protocol we find myocardial viability and a
concomitant reduction of MR, these results should be
interpreted with caution because we cannot assume a
direct effect of the presence of myocardial viability on the
MR. Thus, the complex interplay between haemodynamic
effects of dobutamine, myocardial viability and behaviour
of MR has to be taken in mind during clinical
management of patient with LV dysfunction and ischemic
MR, i.e. revascularization alone versus revascularization
plus mitral valve surgery.
Evaluating the contractile reserve beyond hibernating myocardium
It is commonly believed that the assessment of contractile
reserve is only confined and clinically useful to search the
myocardial viability in patients with LV dysfunction and
coronary artery disease. Growing published data suggest
the utility in searching the presence of contractile reserve in
non ischemic dilated cardiomyopathy (DCM). While in the
ischemic cardiomyopathy the search of myocardial viabil-
ity is focused to find the presence of reversible segmental
myocardial dysfunction and its possible effect on global
systolic LV recovery after revascularization, in DCM the pri-
mary end point is to evaluate the presence of residual glo-
bal contractile reserve. Both dobutamine and exercise
testing have been used in the study patients with DCM, but
there is a clear predominance for the use of dobutamine
test. The doses of dobutamine utilized vary from investiga-
tors, but safety in its use in this population has been docu-
Apical four-chamber view at rest and during exercise in patients with ischemic mitral regurgitation showing a large exercise- induced increase in mitral regurgitation Figure 5
Apical four-chamber view at rest and during exercise in patients with ischemic mitral regurgitation showing a large exercise-
induced increase in mitral regurgitation. SPAP = Systolic pulmonary pressure.Cardiovascular Ultrasound 2004, 2:11 http://www.cardiovascularultrasound.com/content/2/1/11
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mented in doses as high as 40 µg/kg per minute. In the
interpretation of results both wall motion score index and
the LV volume to derive LVEF must be calculated.
LV systolic function at the time of diagnosis has been pro-
posed to be the strongest predictor of survival in DCM,
but now the presence of contractile reserve recognised by
dobutamine echocardiography seems to be the best
marker of good prognosis in patients with severe LV dys-
function at rest [37,38]. Patients with significant improve-
ment in their wall motion score index and LVEF during
dobutamine infusion have a better survival rate and
increase in the LVEF during follow-up period [37]. The
data extracted from dobutamine study can be used as an
adjunct or alternative to predict VO2max and exercise
capacity of patients with heart failure, especially when the
patients fall into the gray zone of VO2max (10–14 ml/kg/
min) or when there is limitation to ambulation [29].
Moreover, the response to dobutamine infusion predicts
the improvement in LVEF with beta-blocker therapy in
patients with advanced heart failure. Patients with con-
tractile reserve experienced a greater improvement in LVEF
with beta-blocker by biologically augmenting myocyte a
chamber contractility [39]. Whereas, in the absence of
contractile reserve (when myocytes have been replaced by
fibrosis), ventricular function cannot improve by this bio-
logical mechanism because there are not enough contrac-
tile units and the sympatholytic effects of beta-blocker
prevail [39]. However, the clinical use of dobutamine
stress echocardiography in patients with chronic heart
failure may be limited by a substantial proportion of
patients already receiving beta-blocker therapy at time of
evaluation. In these patients enoximone echocardiogra-
phy might be a valid alternative to low-dose dobutamine
for evaluating contractile reserve showing a more potent
and a better safety profile than dobutamine [8].
Stress echocardiography may also help in the identifica-
tion of patients in the initial phase of cardiomyopathy
overt normal resting echocardiographic parameters. Both
dobutamine and exercise have to be used to screen for the
presence of latent myocardial dysfunction in patients who
had exposure to cardiotoxic agents [40].
Diastolic heart failure
The prevalence of diastolic heart failure in the community
is now to be at least as high as that reported in previous
studies of hospitalised patients; almost half of all patients
with heart failure have diastolic heart failure [41]. The
term asymptomatic diastolic dysfunction is used to refer
to an asymptomatic patient with a normal LVEF and
abnormal echo-Doppler pattern of LV filling; this is often
seen, for example, in patients with hypertensive heart
disease. If such patients exhibit symptoms of effort intol-
Relationship between contractile reserve, mitral regurgitation and pulmonary pressure and its contribution in defining the  prognosis in patients with functional mitral regurgitation Figure 6
Relationship between contractile reserve, mitral regurgitation and pulmonary pressure and its contribution in defining the 
prognosis in patients with functional mitral regurgitation. MR = mitral regurgitation; sPAP = systolic pulmonary pressure.
MR/sPAP
Contractile
Reserve
Exercise
Prognosis 
Good PoorCardiovascular Ultrasound 2004, 2:11 http://www.cardiovascularultrasound.com/content/2/1/11
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erance and dyspnoea, especially if there are evidence of
venous congestion and edema, the term diastolic heart
failure can be used [42].
Resting echocardiography is most useful in the assessment
of LV size, LVEF and the use of Doppler-derived indices of
diastolic function has impact on the identification of
diastolic dysfunction. However, to determine whether an
abnormality of diastolic function is the cause of the
patient's symptoms, we need to demonstrate the existence
of such dysfunction and determine that it is sufficient to
limit exercise tolerance. Therefore, the stress echocardiog-
raphy, in particular exercise echocardiography could be
useful in dyspnoeic patients with apparently normal LV
function to unmask the presence of diastolic dysfunction
(signs of elevated LV filling pressure) during exercise as
cause of symptoms.
Patients with diastolic heart failure, as well as those with
diastolic dysfunction and little or no congestion, exhibit
exercise intolerance for several reasons. First, an elevated
LV diastolic and pulmonary venous pressure during exer-
cise causes reduction in lung compliance, which increases
work of breathing and evokes the symptom of dyspnoea
[42]. Second, a substantial number of patients who have
LV hypertrophy, high relative wall thickness and small
end diastolic volume exhibit a low stroke volume and a
depressed cardiac output [43]. These hearts exhibit a lim-
ited ability to utilize the Frank-Starling mechanism during
exercise. Such limited preload reserve, specially if coupled
with the chronotropic incompetence limits the cardiac
output during exercise [44]. Third, elevated LV diastolic
and pulmonary venous pressures in patients with normal
LVEF are directly related to abnormalities in the diastolic
proprieties of the ventricle. This is not to say contractile
function is entirely normal, but subtle and latent abnor-
malities of contractile function could be present in many
patients, in whom, however, diastolic dysfunction is the
dominant feature [42].
Targets and effects of dobutamine stress echo in patients with mitral regurgitation and chronic ischemic left ventricular  dysfunction Figure 7
Targets and effects of dobutamine stress echo in patients with mitral regurgitation and chronic ischemic left ventricular dys-
function. EROA = Effective regurgitant orifice area.
Chronic Ischemic MR
with LV dysfunction
Modification of EROA (cm2) 
Dobutamine 
Improve Function
(presence of viability)
Peripheral Effects
(   afterload)
Reduction of Mitral 
Orifice
EROA 
Target
Tool
Effects
ResultsCardiovascular Ultrasound 2004, 2:11 http://www.cardiovascularultrasound.com/content/2/1/11
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All these aspects can be assessed during exercise echocar-
diography (Table 3). In particular the assessment of
diastolic function during exercise has been shown to be
feasible [45]. Combining transmitral flow velocity with
annular velocity obtained at level of the mitral annulus
with tissue Doppler (E/E') has been proposed as a tool for
assessing LV filling pressures that combines the influence
of transmitral driving pressure and myocardial relaxation
[46]. Patients with rest E/E' >15 can be classified as having
elevated filling pressure. A rest E/E' <8 suggests normal
filling pressure and a range of 8 to 15 represents a gray
zone. E and E' velocities increased significantly after exer-
cise. In normal subjects because of proportional increases
of both velocities, the E/E' ratio do not change signifi-
cantly with exercise; this observation can be taken as a
normal diastolic response during exercise [45]. Indeed, if
E/E' ratio increases up to 15 we can suppose a pathologi-
cal increase of LV filling pressure during exercise. This
evaluation must be associated to the assessment of cardiac
output and sPAP during exercise with appearance of
symptoms. Finally, with the evaluation of systolic LV
function during exercise it is possible to discover the por-
tion of patients with concomitant latent myocardial dys-
function but predominant diastolic abnormality (Figure
8).
Aortic stenosis with left ventricular dysfunction
Stress echocardiography with dobutamine infusion is par-
ticularly useful in clinical decision making in patients
with aortic stenosis with LV dysfunction and low transval-
vular gradients. In this group of patients, an important
clinical question rises: is the low gradient a consequence
Schematic diagnostic algorithm in patients with suspected diastolic heart failure Figure 8
Schematic diagnostic algorithm in patients with suspected diastolic heart failure. LV = Left ventricle; LVEF = Left ventricular 
ejection fraction.Cardiovascular Ultrasound 2004, 2:11 http://www.cardiovascularultrasound.com/content/2/1/11
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of low cardiac output due to a severe aortic stenosis which
has led to LV dysfunction or is the low gradient a conse-
quence of LV dysfunction is unrelated to aortic stenosis
and the aortic stenosis is an incidental finding?
It is well known that the transvalvular gradients are flow-
depentent parameters so that they are influenced by LV
function. The aortic valve area can be accurately deter-
mined by Doppler echocardiography with continuity
equation and that correlate well with Gorlin formula [47].
However, it has been shown that valve areas calculated by
the Gorlin formula is flow-dependent and usually
increase with flow, probably due to the flow dependence
of the empirical constant C of the Gorlin formula, which
represents the ratio of effective to anatomical orifice area.
Burwash et al., with dobutamine stress-echocardiography,
demonstrate a flow-dependent increase in actual orifice
aortic valvular area calculated with continuity equation
[48].
Therefore, the assessment of valve area does not solve the
diagnostic dilemma in these patients, because we cannot
distinguish between severe fixed from flow-dependent
(relative) aortic stenosis. Thus, it is important to perform
pharmacological manoeuvres to increase cardiac output
so that valve area can be calculated at higher flow rate.
Dobutamine stress echocardiography until 20 γ/kg/min
with concomitant evaluation of cardiac output, aortic
valve area and gradients, is a useful and reliable test to dis-
tinguish between severe fixed from relative aortic stenosis
in presence of low gradient and LV dysfunction. On the
basis on test results, it is possible to distinguish 3 groups
of patients [49] (Figure 9): 1. Patients with an improve-
ment of contractile function but no significant increase in
valve area and an increase of transvalvular gradients.
These patients have severe fixed aortic stenosis and are
good candidate for surgery with an acceptable peri-opera-
tive surgical risk. 2. Patients with contractile reserve with
an increase of aortic valve area without substantial
increase in transvalvular gradients. These patients have a
non critical aortic stenosis and the LV dysfunction is not
related to the aortic stenosis and should be treated con-
servatively. 3. Finally, patients without contractile reserve
and no modification of valve area and transvalvular gradi-
ents. These patients represent an ambiguous group,
because can represent patients with end-stage severe aortic
stenosis with severe LV dysfunction or patients with severe
LV dysfunction without contractile reserve and incidental
aortic stenosis. However, this group has very poor
prognosis.
When interpreting the results of a dobutamine study in
these patients to rule out or confirm definitively the pres-
ence of a severe fixed aortic stenosis, it is advisable to use
an absolute cut-off value of the aortic valve area at peak of
dobutamine >1 cm2 rather than an increase of ≥ 0.3 cm2
from baseline alone [49,50].
Conclusions
Beyond the identification of viable hibernating myocar-
dium, stress echocardiography is particular useful in
patients with systolic and diastolic heart failure to assess
the different physiopathologic component of heart failure
syndrome and can aid to an appropriate clinical decision
making.
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Table 3: Useful echocardiographic parameters to evaluate 
diastolic function during exercise test in patients with suspected 
diastolic heart failure.
Transmitral Doppler indices
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Cardiac output
Preload reserve
Contractile reserve
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